%0 Journal Article %J The Journal of infectious diseases %D 2010 %T CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users. %A Huik, Kristi %A Sadam, Maarja %A Karki, Tõnis %A Avi, Radko %A Krispin, Tõnu %A Paap, Piret %A Rüütel, Kristi %A Uusküla, Anneli %A Talu, Ave %A Abel-Ollo, Katri %A Lutsar, Irja %K Adult %K Chemokines, CC %K Drug Users %K Estonia %K European Continental Ancestry Group %K Female %K Gene Dosage %K Hepacivirus %K Hepatitis C %K HIV Seropositivity %K Humans %K Immunity, Innate %K Male %K Polymerase Chain Reaction %K Substance Abuse, Intravenous %N 5 %P 730-9 %R 10.1007/s10461-009-9532-3 %V 201 %X A high copy number of CCL3L1, the most potent human immunodeficiency virus (HIV)-suppressive chemokine, associates with reduced HIV susceptibility. Whether CCL3L1 influences acquisition of multiple blood-borne infections (eg, hepatitis C virus [HCV], HIV, and hepatitis B virus [HBV] infections), which occur commonly among injection drug users (IDUs), is unknown. %8 2010 Mar